EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Should HLA and HPA‐matched platelet transfusions for patients with Glanzmann Thrombasthenia or Bernard‐Soulier syndrome be standardized care? A Dutch survey and recommendations

Elise J Huisman iD, Nory Holle, Martin Schipperus, Marjon H Cnossen, Masja de Haas, Leendert Porcelijn, Jaap-Jan Zwaginga

Transfusion · 2024

DOI: 10.1111/trf.17824 ↗

At a glance

Journal article in Transfusion, 2024. Written by Elise J Huisman and 6 co-authors. Institution: Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlan…. Major MEDLINE topics: Platelet Transfusion, Antigens, Human Platelet, Thrombasthenia, Bernard-Soulier Syndrome. Cited 8 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Glanzmann thrombasthenia (GT) and Bernard‐Soulier syndrome (BSS) patients require frequent platelet transfusions and hence have an increased risk for alloimmunization against donor Human Leukocyte Antigens (HLA) when no HLA‐matching is performed. Knowing that Human Platelet Antigens (HPA) are located on the platelet glycoproteins that can be absent in these patients, preventive HPA‐matching may also be considered. Uniform recommendations on this topic lack in transfusion guidelines making standard practice unclear, therefore, we aimed to provide a framework for matched platelet transfusions. Study Design and Methods We conducted a targeted literature search and a national survey of Dutch (pediatric) hematologists from July to September 2021.

Results

We found 20 articles describing platelet transfusion policies in 483 GT‐patients and 29 BSS‐patients, both adults and children. Twenty surveys were returned for full analysis. All responders treated patients with platelet disorders, including GT ( n = 36 reported) and BSS ( n = 29 reported). Of respondents, 75% estimated the risk of antibody formation as “likely” for HLA and 65% for HPA. Formation of HLA antibodies was reported in 5 GT and in 5 BSS‐patients, including one child. Fifteen respondents gave preventive HLA‐matched platelets in elective setting (75%). Three respondents additionally matched for HPA in GT‐patients (15%). Main argument for matched platelet transfusions was preventing alloimmunization to safeguard the effectivity of ‘random’ donor‐platelets in acute settings.

Conclusion

Elective HLA‐matching for GT and BSS‐patients is already conducted by most Dutch (pediatric) hematologists. HPA‐matching is mainly applied when HPA‐antibodies are formed. Based on the current literature and the survey, recommendations are proposed.

Subjects

MeSH terms (MEDLINE)

Platelet TransfusionAntigens, Human PlateletThrombastheniaBernard-Soulier SyndromeHLA AntigensHumansNetherlandsSurveys and QuestionnairesMaleFemaleChild

Author keywords

Bernard‐Soulier syndromeGlanzmann thrombastheniaHLA antigensantibody formationantigens, human plateletblood platelet disordershuman antigens, plateletplatelet transfusion

Substances

Antigens, Human PlateletHLA Antigens

Authors and institutions

  • Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Medical Affairs, Unit of Transfusion Medicine, Sanquin Blood bank, Amsterdam, The Netherlands.
  • Laboratory of Blood Transfusion, Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Immunohematology Diagnostics, Sanquin Diagnostic Services and Sanquin Research, Amsterdam, The Netherlands.
  • Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Laboratory of Platelet and Leucocyte Serology, Sanquin Diagnostic Services and Sanquin Research, Amsterdam, The Netherlands.

ORCID profiles: Elise J Huisman

Cite

APA

Huisman, E. J., Holle, N., Schipperus, M., Cnossen, M. H., de Haas, M., Porcelijn, L., & Zwaginga, J. J. (2024). Should HLA and HPA‐matched platelet transfusions for patients with Glanzmann Thrombasthenia or Bernard‐Soulier syndrome be standardized care? A Dutch survey and recommendations. Transfusion. https://doi.org/10.1111/trf.17824

Vancouver

Huisman EJ, Holle N, Schipperus M, Cnossen MH, de Haas M, Porcelijn L, et al. Should HLA and HPA‐matched platelet transfusions for patients with Glanzmann Thrombasthenia or Bernard‐Soulier syndrome be standardized care? A Dutch survey and recommendations. Transfusion. 2024. doi:10.1111/trf.17824

BibTeX
@article{Huisman2024,
  author = {Huisman, Elise J and Holle, Nory and Schipperus, Martin and Cnossen, Marjon H and de Haas, Masja and Porcelijn, Leendert and Zwaginga, Jaap-Jan},
  title = {Should HLA and HPA‐matched platelet transfusions for patients with Glanzmann Thrombasthenia or Bernard‐Soulier syndrome be standardized care? A Dutch survey and recommendations},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17824}
}
Start for free →